ArticleJournal for immunotherapy of cancer2021

Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade.

Seongju Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.